Applied DNA Sciences, Inc.
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic m… Read more
Applied DNA Sciences, Inc. (BNBX) - Net Assets
Latest net assets as of December 2025: $18.46 Million USD
Based on the latest financial reports, Applied DNA Sciences, Inc. (BNBX) has net assets worth $18.46 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($20.70 Million) and total liabilities ($2.24 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $18.46 Million |
| % of Total Assets | 89.19% |
| Annual Growth Rate | -35.35% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 65.06 |
Applied DNA Sciences, Inc. - Net Assets Trend (2021–2025)
This chart illustrates how Applied DNA Sciences, Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Applied DNA Sciences, Inc. (2021–2025)
The table below shows the annual net assets of Applied DNA Sciences, Inc. from 2021 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $1.94 Million | -78.35% |
| 2024-09-30 | $8.97 Million | +84.06% |
| 2023-09-30 | $4.87 Million | -62.26% |
| 2022-09-30 | $12.91 Million | +16.16% |
| 2021-09-30 | $11.11 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Applied DNA Sciences, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9503828300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.66K | 0.07% |
| Other Components | $381.46 Million | 16551.21% |
| Total Equity | $2.30 Million | 100.00% |
Applied DNA Sciences, Inc. Competitors by Market Cap
The table below lists competitors of Applied DNA Sciences, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mahalaxmi Rubtech Limited
NSE:MHLXMIRU
|
$4.17 Million |
|
Dalaroo Metals Ltd
AU:DAL
|
$4.17 Million |
|
Ravinder Heights Limited
NSE:RVHL
|
$4.17 Million |
|
Palash Securities Limited
NSE:PALASHSECU
|
$4.17 Million |
|
ICZOOM Group Inc. Class A Ordinary Shares
NASDAQ:IZM
|
$4.17 Million |
|
Dom Maklerski IDM SA
WAR:IDM
|
$4.17 Million |
|
Israel Land Development Company Co Ltd
TA:ILDC
|
$4.17 Million |
|
UMS Holdings Bhd
KLSE:7137
|
$4.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Applied DNA Sciences, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,142,617 to 2,304,747, a change of -6,837,870 (-74.8%).
- Net loss of 15,160,724 reduced equity.
- New share issuances of 5,712,700 increased equity.
- Other factors increased equity by 2,610,154.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-15.16 Million | -657.8% |
| Share Issuances | $5.71 Million | +247.87% |
| Other Changes | $2.61 Million | +113.25% |
| Total Change | $- | -74.79% |
Book Value vs Market Value Analysis
This analysis compares Applied DNA Sciences, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.18x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.00x to 0.18x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-09-30 | $22271.88 | $0.80 | x |
| 2022-09-30 | $15013.75 | $0.80 | x |
| 2023-09-30 | $284.01 | $0.80 | x |
| 2024-09-30 | $86.45 | $0.80 | x |
| 2025-09-30 | $4.45 | $0.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Applied DNA Sciences, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -657.80%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -709.46%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 1.93x
- Recent ROE (-657.80%) is below the historical average (-225.55%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -128.55% | -158.25% | 0.63x | 1.30x | $-15.40 Million |
| 2022 | -64.03% | -45.51% | 0.82x | 1.72x | $-9.56 Million |
| 2023 | -200.90% | -74.41% | 0.98x | 2.76x | $-10.44 Million |
| 2024 | -76.48% | -203.78% | 0.27x | 1.40x | $-7.91 Million |
| 2025 | -657.80% | -709.46% | 0.48x | 1.93x | $-15.39 Million |
Industry Comparison
This section compares Applied DNA Sciences, Inc.'s net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $310,488,743
- Average return on equity (ROE) among peers: -23.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Applied DNA Sciences, Inc. (BNBX) | $18.46 Million | -128.55% | 0.12x | $4.17 Million |
| Aberdeen International Inc (AABVF) | $136.31 Million | 25.56% | 0.23x | $2.78 Million |
| Acadian Asset Management Inc (AAMI) | $-17.60 Million | 0.00% | 0.00x | $1.39 Billion |
| AllianceBernstein Holding L.P. (AB) | $402.30 Million | 32.07% | 0.95x | $3.43 Billion |
| VIVO Cannabis Inc (ABCCF) | $164.13 Million | 16.36% | 0.09x | $148.26 Million |
| Associated Capital Group Inc (AC) | $502.13 Million | 5.33% | 0.17x | $42.54 Million |
| Adrian Resources Ltd (ADLRF) | $605.01 Million | 3.35% | 0.58x | $609.82 Million |
| Abrdn Emerging Markets Equity Income Fund Inc (AEF) | $85.10 Million | -65.65% | 0.01x | $77.20K |
| AGF Management Limited (AGFMF) | $1.12 Billion | 10.14% | 3.56x | $298.43 Million |
| Agronomics Limited (AGNMF) | $100.03 Million | 1.02% | 0.02x | $57.14 Million |
| AgriFORCE Growing Systems Ltd (AGRI) | $6.11 Million | -266.31% | 0.76x | $2.71 Million |